Navigation Links
Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients

distribution. 50% of the values are above and 50% below the median.

Monotherapy: treatment with one drug as opposed to combination therapy. Here the term refers to treatment with CYT003-QbG10 alone in contrast to a regimen where CYT003-QbG10 is combined to an allergen extract.

Open-label: a set-up used in clinical trials where the doctor and the patient know what substance is administered; in contrast to e.g. double-blind, placebo-controlled studies, where neither the doctor nor the patient have this knowledge.

Phase IIa: a clinical trial that examines a new drug candidate’s safety and exploratory efficacy and may include between 10 and 100 patients.

Placebo: dummy medical treatment.

QbG10: Cytos Biotechnology’s Immunodrug™ Qb filled with the immunostimulatory DNA sequence G10.

Regimen: describes a treatment schedule according to which a drug is administered.

Th1 and Th2 type immune responses: describe T helper cell responses. T helper cells are a subset of T cells that secrete a variety of mediators (cytokines) playing a role for other immune cells. A Th1 type immune response is usually induced by viral or bacterial infection, or also by potent vaccination / immunotherapy. A Th2 type immune response usually manifests an allergic reaction.

About Cytos Biotechnology AG

Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T-cell responses that modulate chronic disease process
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/3/2015)... 2015 Un fournisseur mondial ... sont l,hypertension, le diabète et les troubles thyroïdiens ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227090 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/3/2015)... July 3, 2015 A global ... hypertension, diabetes and thyroid disorders in Latin ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/2/2015)... -- Pharma Major Lupin Limited anunció ... ZAO "Biocom" en Rusia bajo ciertas condiciones de ... en el mercado farmacéutico de Rusia que registró ... uno de los 10 principales mercados farmacéuticos del ... una década, el mercado farmacéutico ruso registró un ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Combating Three Major Chronic Diseases in Latin America With Medical Education 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Feb. 17, 2011 Stryker Corporation,s Orthopaedics division ... Orthopaedic Surgeons (AAOS) convention that it launched its ... App Store(SM) to help them enhance the patient ... about products and surgical techniques. "Transforming ...
... Delcath Systems, Inc. (Nasdaq: DCTH ... ISO 13485:2003 Certification—an internationally recognized quality standard designed ... necessary comprehensive management systems in place to safely ... the European Union (EU). ISO 13485 Certification is ...
Cached Medicine Technology:Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apple's App Store(SM) 2Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apple's App Store(SM) 3Delcath Achieves ISO 13485 Certification 2
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special (high ... of unlimited classes for just $65. Student ID is needed at registration. , Women's ... Lake Orion. , Women’s Excellence is the most comprehensive obstetric and ...
(Date:7/4/2015)... ... July 04, 2015 , ... When a hacker gains access to someone’s email account, it can ... On Wednesday, July 1st, the FTC issued a scam alert about a social engineering ... process for a password reset instigated by the hacker. All they have to do ...
(Date:7/3/2015)... (PRWEB) , ... July 03, ... ... announced the sessions and speaker lineup for its 2015 Annual Conference ... place August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar Association ... 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law ... of investigating these types of cases. , Each year, New York State residents ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... Almost every smartphone has an incredibly powerful camera built into it. And when someone ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2
... money and an equally aged caregiver sister who is suffering from cancer. ... cannot be left safely on her own, forcing her son to cut ... A 78-year-old Los Angeles man with Alzheimer,s whose daughter will have ... services are cut. These are some of the ...
... remains a mystery, , THURSDAY, Oct. 1 (HealthDay News) -- ... still in their mother,s womb were about 20 percent more ... study has found. , The flu outbreak in 1918 killed ... the United States. That flu, like the current H1N1 swine ...
... ... Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference ... and international harmonization initiatives. , ... Horsham, PA (PRWEB) October 1, 2009 -- The 2nd DIA Conference on Signal ...
... Calif., Oct. 1 Cynthia Perkins, M.Ed., publishes new ... Alcoholism , to provide alcoholics with the little known ... Sober Stay Sober: The Truth About Alcoholism provides ... alcoholism and its successful treatment! Despite past decades of ...
... LA JOLLA, CA September 30, 2009 Researchers at ... characterized a poorly defined component of a key molecular ... also helps cancer cells resist chemotherapy. The research ... the journal Cell . This biological machinethe ...
... Va.SNM is collaborating with the International Partnership for Critical ... and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and ... session, co-hosted by SNM and CMOD, will be held ... p.m. "We are pleased to further extend ...
Cached Medicine News:Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 2Health News:Half-million low-income elderly affected by sweeping cuts to state safety net 3Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 2Health News:International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 3Health News:New Book Provides Alcoholics with Hope for Stable, Long-Term, Craving-Free Sobriety 2Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 2Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 3Health News:Scripps research scientists find missing puzzle piece of powerful DNA repair complex 4Health News:Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics 2
Galilean Loupes...
Surgical Loupes...
... Over 40 cm field-of-view enables high-quality full-coverage ... with scalable 32-channel architecture. New powerful Quasar ... imaging up to 80 mT/m ... management to fully exploit the power of ...
... of doublet objective and high power negative ... 3.0x. The true benefit of this system ... focal clarity is made possible due to ... lightweight aluminum bar and individual interpupillary adjustment ...
Medicine Products: